A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors; Breast Cancer; Recurrent Ovarian Cancer; Prostate Cancer

Interventions: Drug: VIO-01

Sponsors: Valerio Therapeutics

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 15, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments